Prognostic value of NOX2 as a potential biomarker for lung adenocarcinoma using TCGA and clinical validation.
Ontology highlight
ABSTRACT: Lung adenocarcinoma (LUAD) is associated with high morbidity and mortality; therefore, effective biomarkers are essential. In recent years, a rapid increase in the efficiency of high‑throughput sequencing technologies and the continuous improvement of comprehensive online databases have facilitated the study of the genomic changes that affect tumor progression, including the identification of tumor biomarkers. Therefore, the identification of genes that may affect the progression and prognosis of LUAD is necessary. In the present study, the CIBERSORT and ESTIMATE bioinformatics packages were used to evaluate data from The Cancer Genome Atlas, including assessment of the proportion of tumor‑infiltrating immune cells in the tumor microenvironment, Cox regression analysis of differentially ex
SUBMITTER: Liu Y
PROVIDER: S-EPMC9879073 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA